Windtree Therapeutics Liabilities 2024

Windtree Therapeutics Aktienanalyse

What does Windtree Therapeutics do?

Windtree Therapeutics is an emerging biotechnology company based in Pittsburgh, Pennsylvania. The company was founded in 2011 and specializes in the development of innovative therapies for respiratory diseases. Windtree Therapeutics aims to improve the lives of millions of people worldwide by providing effective and safe medications. History: Windtree Therapeutics has a history that dates back to 1990 when it was founded as Advanced Inhalation Research, focusing on the development of therapies for respiratory diseases. After several rounds of financing and mergers, the company was eventually revived as Windtree Therapeutics. Since then, the company has developed and marketed a range of innovative therapies that improve the lives of millions of patients with respiratory diseases. Business model: Windtree Therapeutics is a biotechnology company focused on the development and commercialization of therapies for respiratory diseases. The company has a strong ethos for innovation and works closely with leading medical and scientific experts to develop high-quality and safe products. The company holds a variety of patents and unique technologies that allow it to improve its competitive position in the industry. Segments: Windtree Therapeutics operates in two business segments: PneumRX® Bronchial Tubes and KL4-Surfactant Technology. PneumRX® Bronchial Tubes: One of Windtree Therapeutics' main segments is the PneumRX® Bronchial Tube technology. This technology aims to improve the lives of patients with chronic obstructive pulmonary disease (COPD). The PneumRX® tubes are used as minimally invasive procedures to open the lumen of the bronchial tubes and facilitate breathing. The technology has already been used in thousands of patients worldwide and is highly regarded by physicians. KL4-Surfactant Technology: Windtree Therapeutics is also known for its KL4-Surfactant Technology, which aims to treat respiratory distress syndrome in newborns. The company has already conducted a number of clinical studies, and the results have been very promising. The KL4-Surfactant Technology is considered one of the most promising treatment options for respiratory problems in newborns. Products: Windtree Therapeutics has a range of products on the market, including: Aer-OS Nitric Oxide Inhalation Device: The Aer-OS Nitric Oxide Inhalation Device is a medical device for patients with pulmonary hypertension. It is the first and only portable nitric oxide inhalation device approved for use at home and on-the-go. The device is used to facilitate breathing and improve patients' quality of life. PneumRX® Bronchial Tubes: The PneumRX® Bronchial Tube technology has already been performed in thousands of patients and is highly regarded by physicians. The technology aims to open the lumen of the bronchial tubes and facilitate breathing. The procedures are minimally invasive and result in minimal injuries. Patients often experience significant improvement in their breathing and overall well-being. KL4-Surfactant Technology: Windtree Therapeutics' KL4-Surfactant Technology is a promising treatment option for respiratory problems in newborns. The technology aims to stimulate lung growth and facilitate breathing. The results of clinical studies have been very promising, and the treatment is considered one of the most promising treatment options for respiratory problems in newborns. In conclusion, Windtree Therapeutics is an emerging biotechnology company with a strong ethos for innovation and the development of therapies for respiratory diseases. The PneumRX® Bronchial Tube technology and KL4-Surfactant Technology are two of the company's main segments. Both technologies are promising and have the potential to improve the lives of millions of patients worldwide. Windtree Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Windtree Therapeutics's Liabilities

Windtree Therapeutics's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Windtree Therapeutics's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Windtree Therapeutics's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Windtree Therapeutics's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Windtree Therapeutics’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Windtree Therapeutics stock

What is the level of liabilities of Windtree Therapeutics this year?

Windtree Therapeutics has a debt balance of 29.01 M USD this year.

What were the liabilities of Windtree Therapeutics compared to the previous year?

The liabilities of Windtree Therapeutics have increased by 3.84% increased compared to the previous year.

What are the consequences of high debt for investors of Windtree Therapeutics?

High liabilities can pose a risk for investors of Windtree Therapeutics, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Windtree Therapeutics?

Low liabilities mean that Windtree Therapeutics has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Windtree Therapeutics affect the company?

An increase in liabilities of Windtree Therapeutics can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Windtree Therapeutics affect the company?

A decrease in the liabilities of Windtree Therapeutics can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Windtree Therapeutics?

Some factors that can influence the liabilities of Windtree Therapeutics include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Windtree Therapeutics so important for investors?

The liabilities of Windtree Therapeutics are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Windtree Therapeutics take to modify the liabilities?

To change its liabilities, Windtree Therapeutics can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Windtree Therapeutics pay?

Over the past 12 months, Windtree Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Windtree Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Windtree Therapeutics?

The current dividend yield of Windtree Therapeutics is .

When does Windtree Therapeutics pay dividends?

Windtree Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Windtree Therapeutics?

Windtree Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Windtree Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Windtree Therapeutics located?

Windtree Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Windtree Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Windtree Therapeutics from 11/8/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/8/2024.

When did Windtree Therapeutics pay the last dividend?

The last dividend was paid out on 11/8/2024.

What was the dividend of Windtree Therapeutics in the year 2023?

In the year 2023, Windtree Therapeutics distributed 0 USD as dividends.

In which currency does Windtree Therapeutics pay out the dividend?

The dividends of Windtree Therapeutics are distributed in USD.